These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 25435188)
1. Color vision in attention-deficit/hyperactivity disorder: a pilot visual evoked potential study. Kim S; Banaschewski T; Tannock R J Optom; 2015; 8(2):116-30. PubMed ID: 25435188 [TBL] [Abstract][Full Text] [Related]
2. Visual function and color vision in adults with Attention-Deficit/Hyperactivity Disorder. Kim S; Chen S; Tannock R J Optom; 2014; 7(1):22-36. PubMed ID: 24646898 [TBL] [Abstract][Full Text] [Related]
3. Visual-evoked potentials to onset of chromatic red-green and blue-yellow gratings in Parkinson's disease never treated with L-dopa. Sartucci F; Porciatti V J Clin Neurophysiol; 2006 Oct; 23(5):431-5. PubMed ID: 17016154 [TBL] [Abstract][Full Text] [Related]
4. Color vision in ADHD: part 2--does attention influence color perception? Kim S; Al-Haj M; Fuller S; Chen S; Jain U; Carrasco M; Tannock R Behav Brain Funct; 2014 Oct; 10():39. PubMed ID: 25344205 [TBL] [Abstract][Full Text] [Related]
6. Colour vision in ADHD: part 1--testing the retinal dopaminergic hypothesis. Kim S; Al-Haj M; Chen S; Fuller S; Jain U; Carrasco M; Tannock R Behav Brain Funct; 2014 Oct; 10():38. PubMed ID: 25344625 [TBL] [Abstract][Full Text] [Related]
7. Color perception deficits in co-existing attention-deficit/hyperactivity disorder and chronic tic disorders. Roessner V; Banaschewski T; Fillmer-Otte A; Becker A; Albrecht B; Uebel H; Sergeant J; Tannock R; Rothenberger A J Neural Transm (Vienna); 2008; 115(2):235-9. PubMed ID: 17896072 [TBL] [Abstract][Full Text] [Related]
8. Defective chromatic and achromatic visual pathways in developmental dyslexia: Cues for an integrated intervention programme. Bonfiglio L; Bocci T; Minichilli F; Crecchi A; Barloscio D; Spina DM; Rossi B; Sartucci F Restor Neurol Neurosci; 2017; 35(1):11-24. PubMed ID: 27858722 [TBL] [Abstract][Full Text] [Related]
9. Luminance and chromatic visual evoked potentials in type I and type II diabetes: relationships with peripheral neuropathy. Gregori B; Galié E; Pro S; Clementi A; Accornero N Neurol Sci; 2006 Nov; 27(5):323-7. PubMed ID: 17122941 [TBL] [Abstract][Full Text] [Related]
10. Changes in pattern electroretinograms to equiluminant red-green and blue-yellow gratings in patients with early Parkinson's disease. Sartucci F; Orlandi G; Lucetti C; Bonuccelli U; Murri L; Orsini C; Porciatti V J Clin Neurophysiol; 2003; 20(5):375-81. PubMed ID: 14701999 [TBL] [Abstract][Full Text] [Related]
11. Chromatic modulation of luminance visual evoked potential latencies in healthy subjects and patients with mild vision disorders. Accornero N; Gregori B; Pro S; Scappini G; La Riccia M Clin Neurophysiol; 2008 Jul; 119(7):1683-8. PubMed ID: 18455475 [TBL] [Abstract][Full Text] [Related]
12. Amplitude of the transient visual evoked potential (tVEP) as a function of achromatic and chromatic contrast: contribution of different visual pathways. Souza GS; Gomes BD; Lacerda EM; Saito CA; da Silva Filho M; Silveira LC Vis Neurosci; 2008; 25(3):317-25. PubMed ID: 18321403 [TBL] [Abstract][Full Text] [Related]
13. Neuroelectrical signs of selective attention to color in boys with attention-deficit hyperactivity disorder. van der Stelt O; van der Molen M; Boudewijn Gunning W; Kok A Brain Res Cogn Brain Res; 2001 Oct; 12(2):245-64. PubMed ID: 11587894 [TBL] [Abstract][Full Text] [Related]
14. Vision abnormalities in young children exposed prenatally to organic solvents. Till C; Westall CA; Koren G; Nulman I; Rovet JF Neurotoxicology; 2005 Aug; 26(4):599-613. PubMed ID: 16054697 [TBL] [Abstract][Full Text] [Related]
16. [The specific nature of the color and brightness components of the human visual evoked potential]. Izmaĭlov ChA; Isaĭchev SA; Korshunova SG; Sokolov EN Zh Vyssh Nerv Deiat Im I P Pavlova; 1998; 48(5):777-87. PubMed ID: 9949527 [TBL] [Abstract][Full Text] [Related]
20. Color stimuli perception in presence of light scattering. Ozolinsh M; Colomb M; Ikaunieks G; Karitans V Vis Neurosci; 2006; 23(3-4):597-601. PubMed ID: 16962002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]